Zoetis Simparica (Sarolaner) Tick and Flea Control Chewable Tablet for Dogs – 1 Tablet

Zoetis Simparica (Sarolaner) Tick and Flea Control Tablet for Dogs is an oral ectoparasiticide formulated for the treatment and control of tick and flea infestations in dogs.

Each chewable tablet contains Sarolaner, an active ingredient belonging to the isoxazoline class. After oral administration, Sarolaner is absorbed systemically. Ticks and fleas are exposed to the active ingredient when they feed on the treated dog.

The supplied product information states that Simparica begins killing fleas within 3 hours and ticks within 8 hours. It is administered approximately once monthly for continued parasite control.

Active Ingredient

Sarolaner

Drug Class

Isoxazoline ectoparasiticide

Available Variants

Dog WeightSarolaner StrengthPack Size10–20 kg20 mg1 Tablet20–40 kg40 mg1 Tablet

Always select the appropriate strength according to the dog's current body weight and veterinary recommendation.

Uses

• Treatment and control of flea infestations

• Treatment and control of tick infestations

• Helps kill adult fleas

• Provides systemic ectoparasite control

• Monthly oral parasite-control option for dogs

Key Product Features

• Contains Sarolaner

• Oral chewable tablet

• Systemic tick and flea control

• Flea-killing activity begins within 3 hours according to supplied product information

• Tick-killing activity begins within 8 hours according to supplied product information

• Monthly administration

• Weight-based tablet strengths

• For dogs aged 6 months and above

• Single-tablet pack

Directions for Use

Administer orally according to your veterinarian's instructions and the dog's current body weight.

The tablet can be administered with or without food.

For continuous protection, the supplied product information describes administration approximately once every 30 days.

Do not select a higher-strength tablet simply for convenience. Confirm the dog's current body weight and use the appropriate product strength as directed by a veterinarian.

Important Safety Information

Sarolaner belongs to the isoxazoline class. Isoxazolines have been associated with neurological adverse reactions in some dogs, including:

• Tremors

• Ataxia or loss of coordination

• Seizures

Use with particular caution in dogs with a history of seizures, epilepsy, or other neurological disorders and discuss the treatment specifically with a veterinarian before administration.

The supplied information also notes:

• For dogs 6 months of age and above

• Safety has not been established in breeding, pregnant, or lactating dogs

• Confirm the dog's exact body weight before selecting the tablet strength

• Keep out of reach of children

If unusual neurological signs or other significant adverse reactions occur after administration, contact a veterinarian promptly.

Simparica vs Simparica Trio

Do not confuse Simparica with Simparica Trio.

Simparica:
Contains Sarolaner only and is intended for tick and flea control.

Simparica Trio:
Contains Sarolaner + Moxidectin + Pyrantel and has additional parasite coverage.

Always verify the exact product prescribed before purchasing or administering it.

Prescription Information

Prescription veterinary medicine – use under veterinary guidance.

Dispensing and online sale should follow applicable veterinary pharmacy requirements and the prescription supplied by a registered veterinarian.

Manufacturer

Manufactured by: Zoetis Inc., Lincoln, Nebraska, USA
Marketed by: Zoetis India Limited

Storage

Store in a cool, dry place away from direct sunlight and keep out of reach of children.